Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s13337-021-00691-6 http://scihub22266oqcxt.onion/10.1007/s13337-021-00691-6 33948452!8083918!33948452     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Virusdisease 2021 ; 32 (2): 279-285 Nephropedia Template TP {{tp|p=33948452|t=2021. Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors |pdf=|usr=}}{{33948452}} gab.com Text Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors JO: Virusdisease http://www.kidney.de/pget.php?&tw=1&pmid=33948452 #FOAvip The coronavirus pandemic could be the most threatening outbreak in the twenty-first century. According to the latest records of world health organization, more than 130 millions have been infected by COVID-19, with more than 2.9 million reported deaths. Yet, there is no magic cure for treatment of COVID-19. The concept of drug repurposing has been introduced as a fast, life-saving approach for drug discovery. Drug repurposing infers investigating already approved drugs for new indications, using the available information about pathophysiology of diseases and pharmacodynamics of drugs. In a recent work, more than 3000 FDA approved drugs were tested using virtual screening as potential antiviral agents for COVID-19. In this work, the top ranked five hits from the previous docking results together with drugs of similar chemical feature and/or mechanistic destinations were further tested using AutoDock Vina. The results showed that anti-HCV combinations could be potential therapeutic regimens for COVID-19 infections. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13337-021-00691-6. Twit Text FOAVip Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors ????Virusdisease http://www.kidney.de/pget.php?&tw=1&pmid=33948452 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33948452 #FOAvip English Wikipedia <ref>{{Cite pmid|33948452}}</ref> Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors #MMPMID33948452 Hamed M; El-Hasab M; Mansour FR Virusdisease 2021[Jun]; 32 (2): 279-285 PMID33948452show ga The coronavirus pandemic could be the most threatening outbreak in the twenty-first century. According to the latest records of world health organization, more than 130 millions have been infected by COVID-19, with more than 2.9 million reported deaths. Yet, there is no magic cure for treatment of COVID-19. The concept of drug repurposing has been introduced as a fast, life-saving approach for drug discovery. Drug repurposing infers investigating already approved drugs for new indications, using the available information about pathophysiology of diseases and pharmacodynamics of drugs. In a recent work, more than 3000 FDA approved drugs were tested using virtual screening as potential antiviral agents for COVID-19. In this work, the top ranked five hits from the previous docking results together with drugs of similar chemical feature and/or mechanistic destinations were further tested using AutoDock Vina. The results showed that anti-HCV combinations could be potential therapeutic regimens for COVID-19 infections. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13337-021-00691-6. äDirect acting anti-hepatitis C combinations as potential COVID-19 prot(epmc).pdf DeepDyve Pubget Overpricing